OncBioMune Pharmaceuticals competitorsClear all
Northwest Biotherapeutics's top competitors include Merrimack Pharmaceuticals, CytomX Therapeutics and AVEO Pharmaceuticals.
| Save Comparison |  Northwest Biotherapeutics Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer. |  Merrimack Pharmaceuticals Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer. |  CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. |  AVEO Pharmaceuticals AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics. |
Founding Date | Founding Date 1998 | Founding Date 2000 | Founding Date 2008 | Founding Date 2001 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Bethesda, US HQ | Locations Cambridge, US HQ | Locations South San Francisco, US HQ | Locations Cambridge, US HQ Boston, US |
Employees | Employees 1721% increase | Employees 2763% decrease | Employees 15815% increase | Employees 1912% increase |
Valuation ($) | Valuation ($) 1.2 b | Valuation ($) 101.2 m | Valuation ($) 307.4 m | Valuation ($) 241.7 m |
Twitter followers | Twitter followers 2.3 k | Twitter followers 1.1 k | Twitter followers 889 | Twitter followers 907 |
Alexa Website Rank | Alexa Website Rank 616184 | Alexa Website Rank 411721 | Alexa Website Rank 281860 | Alexa Website Rank 419832 |
Employee Rating | Employee Rating N/A | Employee Rating 3 | Employee Rating 3.4 | Employee Rating 3.7 |
Financial | ||||
Revenue (est.) | Revenue (est.) $2.4m (FY, 2019) | Revenue (est.) N/A | Revenue (est.) $57.5m (FY, 2019) | Revenue (est.) $28.8m (FY, 2019) |
Net income | Net income ($20.3m) (FY, 2019) | Net income ($17.3m) (FY, 2019) | Net income ($102.2m) (FY, 2019) | Net income $9.4m (FY, 2019) |
Funding | ||||
Total funding raised | Total funding raised $ 135.9m | Total funding raised $ 79.4m | Total funding raised $ 132.4m | Total funding raised $ 224m |
For sources of this data, please see the company profile
View company profiles
Merrimack Pharmaceuticals
HQ
Cambridge, US
Employees
27
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
View companyCytomX Therapeutics
HQ
South San Francisco, US
Employees
158↑ 15% increase
CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
View companyAVEO Pharmaceuticals
HQ
Cambridge, US
Employees
19↑ 12% increase
AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.
View company